Does a newborn with jaundice of 16.2 μmol/L need blue light therapy?
May 04, 2023
Source: Cainiu Health
Dr. Ma Yan
Introduction
A newborn with jaundice measuring 16.2 μmol/L requires blue light therapy. Phototherapy is indicated when neonatal jaundice exceeds 12.9 μmol/L. Therefore, if a newborn's bilirubin level is 16.2 μmol/L and phototherapy is not administered, it may lead to yellowing of the sclera, skin, and mucous membranes, and even cause symptoms such as fever, skin itching, abdominal pain, hepatobiliary enlargement, and gastrointestinal bleeding.
Generally, newborn jaundice with a bilirubin level of 16.2 μmol/L requires blue light therapy to prevent worsening symptoms. The detailed explanation is as follows:
Newborn jaundice results from impaired bilirubin metabolism, leading to elevated serum bilirubin levels. Under normal circumstances, blue light therapy is recommended when bilirubin exceeds 12.9 μmol/L. Therefore, when a newborn's bilirubin level measures 16.2 μmol/L, phototherapy is necessary. Without treatment, the infant may develop yellowing of the sclera, skin, and mucous membranes, and could even experience complications such as fever, skin itching, abdominal pain, hepatobiliary enlargement, or gastrointestinal bleeding.
While undergoing blue light therapy, it is also essential to identify the underlying cause of the jaundice and actively treat the root condition.
